Company / Free Cash Flow
Processa Pharmaceuticals, Inc. Free Cash Flow History
FY2013-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$873.3K
FY2016
5-year range
-$2.7M / -$873.3K
FY2013-FY2016
Trend
+67.7%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow returned to growth in FY2016 after 2 years of decline, reaching -$873,305.
Based on SEC 10-K filings.
-$873,305 in FY2016.
Improved from -$3M to -$873,305 over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, free cash flow increased 67.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | - | - |
| FY2016 | -$873.3K | +67.7% |
| FY2015 | -$2.7M | -5.3% |
| FY2014 | -$2.6M | -15.3% |
| FY2013 | -$2.2M | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026